Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

Punt, CJA; Keizer, HJ; Douma, J; Schuller, J; Skovsgaard, T; ten Napel, CHH; Lochs, H; Muller, EW; Russell, L; Wagener, DJT

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

journal contribution

posted on 2025-06-05, 06:24 authored by CJA Punt, HJ Keizer, J Douma, J Schuller, T Skovsgaard, CHH ten Napel, H Lochs, EW Muller, L Russell, DJT Wagener

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

History

Journal

EUROPEAN JOURNAL OF CANCER

Volume

35

Pagination

S68-S68

ISSN

0959-8049

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083068300203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

Publication URL

http://dx.doi.org/10.1016/s0959-8049(99)80638-8

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

History

Journal

Volume

Pagination

ISSN

Language

Author URL

Publication classification

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports